Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies

Gregory J. Fulchiero, Heather Salvaggio, Joseph J. Drabick, Kevin Staveley-O'Carroll, Elizabeth M. Billingsley, James G. Marks, Klaus F. Helm

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Abstract

We report two cases of late recurrence of eruptive locoregional metastatic melanoma occurring 6 and 9 years after definitive surgical treatment. Each case (stage IB and IA) occurred after initiation of the subcutaneous anti-tumor necrosis factor medications etanercept and adalimumab, respectively. We discuss the association of immune suppression and melanoma. These cases illustrate a previously unrecognized and potentially causal relationship between tumor necrosis factor-α inhibition and reactivation of latent melanoma.

Original languageEnglish (US)
Pages (from-to)S65-S67
JournalJournal of the American Academy of Dermatology
Volume56
Issue number5 SUPPL.
DOIs
StatePublished - May 1 2007

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint

Dive into the research topics of 'Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies'. Together they form a unique fingerprint.

Cite this